WallStreetZen

NYSE: JNJ
Johnson & Johnson Stock Forecast, Predictions & Price Target

Analyst price target for JNJ

Based on 4 analysts offering 12 month price targets for Johnson & Johnson.
Min Forecast
$178.00+8.96%
Avg Forecast
$189.50+16%
Max Forecast
$200.00+22.43%

Should I buy or sell JNJ stock?

Based on 4 analysts offering ratings for Johnson & Johnson.
Buy
Strong Buy
0 analysts 0%
Buy
3 analysts 75%
Hold
1 analysts 25%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

JNJ stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Raymond James
Top 13%
88
BuyMaintains$178.00+8.96%2021-10-20
Morgan Stanley
Top 30%
71
HoldDowngrades$187.00+14.47%2021-09-07
Credit Suisse
Top 23%
78
BuyMaintains$193.00+18.14%2021-01-27
Anonymous
Morgan Stanley
Strong BuyMaintains$187.00+14.47%2021-01-27
SVB Leerink
Bottom 4%
4
BuyMaintains$200.00+22.43%2021-01-27

1 of 1

Forecast return on equity

Is JNJ forecast to generate an efficient return?
Company
43.94%
Industry
67.27%
Market
37.02%
JNJ's Return on Equity is forecast to be high in 3 years (43.94%); analysts are confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is JNJ forecast to generate an efficient return on assets?
Company
17.23%
Industry
15.85%
JNJ is forecast to generate higher Return on Assets (17.23%) than the US Drug Manufacturers - General industry average (15.85%)
Forecast

JNJ earnings per share forecast

What is JNJ's earnings per share in the next 3 years based on estimates from 9 analysts?
Avg 1 year Forecast
$9.65+42.33%
Avg 2 year Forecast
$10.30+51.92%
Avg 3 year Forecast
$11.14+64.31%
JNJ's earnings are forecast to grow at a rate of 17.75% per year, which is not exceptional
Forecast

JNJ revenue forecast

What is JNJ's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$94.2B+3.04%
Avg 2 year Forecast
$98.4B+7.66%
Avg 3 year Forecast
$102.1B+11.66%
JNJ's revenue is forecast to grow at a rate of 3.78% per year, which is not exceptional
Forecast

JNJ earnings growth forecast

How is JNJ forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
17.75%
Industry
23.23%
Market
14.37%
JNJ's earnings are forecast to grow slower (17.75% per year) than the US Drug Manufacturers - General industry average (23.23%)
Forecast
JNJ's earnings are forecast to grow faster (17.75% per year) than the US market average (14.37%)
Forecast
JNJ's earnings are forecast to grow faster (17.75% per year) than the risk-free savings rate (1.5%)
Forecast

JNJ revenue growth forecast

How is JNJ forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
3.78%
Industry
4.01%
Market
10.03%
JNJ's revenues are forecast to grow slower (3.78% per year) than the US Drug Manufacturers - General industry average (4.01%)
Forecast
JNJ's revenues are forecast to grow slower (3.78% per year) than the US market average (10.03%)
Forecast

Johnson & Johnson Stock Forecast FAQ

Is Johnson & Johnson Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NYSE: JNJ) stock is to Buy JNJ stock.

Out of 4 analysts, 0 (0%) are recommending JNJ as a Strong Buy, 3 (75%) are recommending JNJ as a Buy, 1 (25%) are recommending JNJ as a Hold, 0 (0%) are recommending JNJ as a Sell, and 0 (0%) are recommending JNJ as a Strong Sell.

What is JNJ's earnings growth forecast for 2021-2023?

(NYSE: JNJ) Johnson & Johnson's forecast annual earnings growth rate of 17.75% is not forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 23.23%, and while it is forecast to beat the US market's average forecast earnings growth rate of 14.37%.

Johnson & Johnson's earnings in 2021 is $17,880,000,000.On average, 9 Wall Street analysts forecast JNJ's earnings for 2021 to be $25,404,560,751, with the lowest JNJ earnings forecast at $25,272,930,902, and the highest JNJ earnings forecast at $25,483,538,660. On average, 9 Wall Street analysts forecast JNJ's earnings for 2022 to be $27,115,748,781, with the lowest JNJ earnings forecast at $25,220,278,963, and the highest JNJ earnings forecast at $27,773,898,023.

In 2023, JNJ is forecast to generate $29,327,130,235 in earnings, with the lowest earnings forecast at $28,774,284,871 and the highest earnings forecast at $29,748,345,750.

What is JNJ's revenue growth forecast for 2021-2023?

(NYSE: JNJ) Johnson & Johnson's forecast annual revenue growth rate of 3.78% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 4.01%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.03%.

Johnson & Johnson's revenue in 2021 is $91,446,000,000.On average, 5 Wall Street analysts forecast JNJ's revenue for 2021 to be $248,062,314,830,072, with the lowest JNJ revenue forecast at $247,714,922,599,237, and the highest JNJ revenue forecast at $248,390,789,219,088. On average, 5 Wall Street analysts forecast JNJ's revenue for 2022 to be $259,171,363,315,440, with the lowest JNJ revenue forecast at $256,414,944,780,600, and the highest JNJ revenue forecast at $262,203,104,106,492.

In 2023, JNJ is forecast to generate $268,808,500,509,470 in revenue, with the lowest revenue forecast at $265,884,185,470,335 and the highest revenue forecast at $272,860,778,045,943.

What is JNJ's forecast return on assets (ROA) for 2021-2024?

(NYSE: JNJ) forecast ROA is 17.23%, which is higher than the forecast US Drug Manufacturers - General industry average of 15.85%.

What is JNJ's Price Target?

According to 4 Wall Street analysts that have issued a 1 year JNJ price target, the average JNJ price target is $189.50, with the highest JNJ stock price forecast at $200.00 and the lowest JNJ stock price forecast at $178.00.

On average, Wall Street analysts predict that Johnson & Johnson's share price could stay at $189.50 by Oct 20, 2022. The average Johnson & Johnson stock price prediction forecasts a potential downside of N/A from the current JNJ share price of $163.36.

What is JNJ's Earnings Per Share (EPS) forecast for 2021-2023?

(NYSE: JNJ) Johnson & Johnson's current Earnings Per Share (EPS) is $6.78. On average, analysts forecast that JNJ's EPS will be $9.65 for 2021, with the lowest EPS forecast at $9.60, and the highest EPS forecast at $9.68. On average, analysts forecast that JNJ's EPS will be $10.30 for 2022, with the lowest EPS forecast at $9.58, and the highest EPS forecast at $10.55. In 2023, JNJ's EPS is forecast to hit $11.14 (min: $10.93, max: $11.30).

What is JNJ's forecast return on equity (ROE) for 2021-2024?

(NYSE: JNJ) forecast ROE is 43.94%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.